PRTK Annual Total Long Term Liabilities
$306.19 M
+$25.83 M+9.21%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual total long term liabilities is $306.19 million, with the most recent change of +$25.83 million (+9.21%) on December 31, 2022. During the last 3 years, it has risen by +$39.67 million (+14.88%).PRTK Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Long Term Liabilities
$144.54 M
-$162.58 M-52.94%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly total long term liabilities is $144.54 million, with the most recent change of -$162.58 million (-52.94%) on June 30, 2023. Over the past year, it has dropped by -$138.42 million (-48.92%).PRTK Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.2% | -48.9% |
| 3 y3 years | +14.9% | -43.7% |
| 5 y5 years | +375.2% | -30.6% |
PRTK Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -52.9% |
Paratek Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $144.54 M(-52.9%) |
| Mar 2023 | - | $307.12 M(+0.3%) |
| Dec 2022 | $306.19 M(+9.2%) | $306.19 M(+7.6%) |
| Sept 2022 | - | $284.50 M(+0.5%) |
| June 2022 | - | $282.96 M(+0.5%) |
| Mar 2022 | - | $281.62 M(+0.5%) |
| Dec 2021 | $280.36 M(+9.9%) | $280.36 M(+8.6%) |
| Sept 2021 | - | $258.19 M(+0.1%) |
| June 2021 | - | $257.90 M(+1.0%) |
| Mar 2021 | - | $255.33 M(+0.1%) |
| Dec 2020 | $255.16 M(-4.3%) | $255.16 M(-0.2%) |
| Sept 2020 | - | $255.67 M(-0.4%) |
| June 2020 | - | $256.66 M(+4.4%) |
| Mar 2020 | - | $245.79 M(-7.8%) |
| Dec 2019 | $266.53 M(+13.5%) | $266.53 M(-0.7%) |
| Sept 2019 | - | $268.36 M(+0.1%) |
| June 2019 | - | $268.17 M(+12.9%) |
| Mar 2019 | - | $237.43 M(+1.1%) |
| Dec 2018 | $234.91 M(+264.6%) | $234.91 M(+0.2%) |
| Sept 2018 | - | $234.52 M(+12.6%) |
| June 2018 | - | $208.34 M(+264.5%) |
| Mar 2018 | - | $57.16 M(-11.3%) |
| Dec 2017 | $64.43 M(+47.3%) | $64.43 M(+19.2%) |
| Sept 2017 | - | $54.06 M(+0.6%) |
| June 2017 | - | $53.72 M(+22.3%) |
| Mar 2017 | - | $43.92 M(+0.4%) |
| Dec 2016 | $43.73 M(+80.9%) | $43.73 M(+79.3%) |
| Sept 2016 | - | $24.39 M(-0.3%) |
| June 2016 | - | $24.47 M(+0.4%) |
| Mar 2016 | - | $24.37 M(+0.8%) |
| Dec 2015 | $24.18 M(+119.7%) | $24.18 M(-10.4%) |
| Sept 2015 | - | $26.98 M(+248.4%) |
| June 2015 | - | $7.75 M(+2.3%) |
| Mar 2015 | - | $7.57 M(-31.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $11.00 M(>+9900.0%) | $11.00 M(>+9900.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(-100.0%) |
| Mar 2012 | - | $39.00 K(-35.0%) |
| Dec 2011 | $60.00 K(-82.8%) | $60.00 K(-36.2%) |
| Sept 2011 | - | $94.00 K(-46.9%) |
| June 2011 | - | $177.00 K(-32.2%) |
| Mar 2011 | - | $261.00 K(-25.0%) |
| Dec 2010 | $348.00 K(-95.7%) | $348.00 K(-20.2%) |
| Sept 2010 | - | $436.00 K(-72.0%) |
| June 2010 | - | $1.56 M(-67.6%) |
| Mar 2010 | - | $4.81 M(-40.3%) |
| Dec 2009 | $8.06 M(-88.8%) | $8.06 M(-29.0%) |
| Sept 2009 | - | $11.36 M(+1197.8%) |
| June 2009 | - | $875.10 K(-2.9%) |
| Mar 2009 | - | $901.10 K(-98.7%) |
| Dec 2008 | $71.97 M(+60.3%) | $71.97 M(>+9900.0%) |
| Sept 2008 | - | $64.00 K(+18.5%) |
| June 2008 | - | $54.00 K(+20.0%) |
| Mar 2008 | - | $45.00 K(-99.9%) |
| Dec 2007 | $44.91 M(-58.4%) | $44.91 M(-5.2%) |
| Sept 2007 | - | $47.38 M(-5.0%) |
| June 2007 | - | $49.90 M(-53.9%) |
| Mar 2006 | - | $108.33 M(+0.3%) |
| Dec 2005 | $108.02 M(+30.2%) | $108.02 M(+30.2%) |
| Dec 2004 | $82.94 M | $82.94 M |
FAQ
- What is Paratek Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Paratek Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Paratek Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of PRTK is $306.19 M
What is the all time high annual total long term liabilities for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual total long term liabilities is $306.19 M
What is Paratek Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, PRTK annual total long term liabilities has changed by +$25.83 M (+9.21%)
What is Paratek Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of PRTK is $144.54 M
What is the all time high quarterly long term liabilities for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly total long term liabilities is $307.12 M
What is Paratek Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, PRTK quarterly total long term liabilities has changed by -$138.42 M (-48.92%)